Jaiprakash Associates

Size: px
Start display at page:

Download "Jaiprakash Associates"

Transcription

1 BSE SENSEX S&P CNX 16,312 4,951 Bloomberg JPA IN Equity Shares (m) 2, Week Range (INR) 89/50 1,6,12 Rel. Perf. (%) -14/-4/-17 M.Cap. (INR b) M.Cap. (USD b) May QFY12 Results Update Sector: Infrastructure Jaiprakash Associates CMP: INR60 TP: INR103 Buy * Not Fully Diluted; FCCB O/s of INR14b at conversion price of INR166/sh (dilution of ~5%) 4QFY12 EBITDA/PAT above estimates: During 4QFY12, Jaiprakash Associates reported standalone revenues of INR41b (up 4% YoY), EBITDA of INR10b (up 32 % YoY), and net profit stood of INR2.8b (down 3.3% YoY). Reported EBIDTA/PAT is better than our estimate of INR32b and INR6.8b, respectively. Operating performance is driven by higher EPC / RE division, while performance of Cement division was muted. Interest cost for the quarter was higher at INR5.8b (vs INR4.5b QoQ), which negated gain on operational front. Lower Tax/PBT ratio (9%) however arrested PAT de-growth (PBT down 19% YoY). Cement business performance muted: Cement division sales for 4QFY12 stood at 4.25m tons (flat QoQ) pertaining to JAL (Gujarat cement plant divested in Jaypee Cement - 100% subsidiary). Realisation / EBIDTA for the division was up by INR25/ton and INR82/ton QoQ. EBIT for the division however stood flat at INR2.1b owing to higher depreciation. E&C business performance driven by higher margin: EPC division performance was driven by superior margin (EBIT margin at 24%, while revenue down 1% YoY) due to completion of Yamuna Expressway, Karcham Wangtoo project, etc. Real estate division revenues picked up after 3-quarters of lull performance, which along with higher EBIT margin (45% for 4Q) led to higher positive contribution QoQ. Focus on deleverage (consolidated FY12 net DER at 3.8x): For JPA group, the earnings/cashflows will be driven by commissioning of projects across its cement (10m tons), power (1.5GW), infrastructure (toll road project, INR133b cost) and real estate (traction in launches, bookings) business. JPA group plans to focus on consolidation and de-leveraging (consolidated net DER of 3.8x as at March 2012) and is exploring various options. Downgrading FY13/14E estimates, maintain Buy: We marginally downgrade (2-4%) our earnings for JPA to factor in higher interest cost, which is partially set-off due to strong cement realisation, EPC/RE business traction. We now expect JPA to report standalone net profit of INR8.2b in FY13E (down 20% YoY) and INR11.1b in FY14E (up 37% YoY). Maintain Buy with TP of INR103/sh. Nalin Bhatt (NalinBhatt@MotilalOswal.com); Satyam Agarwal (Agarwals@MotilalOswal.com) / Pooja Kachhawa (Pooja.Kachhawa@MotilalOswal.com)

2 Cement division performance 4QFY12 results above estimate, higher interest set-off operating performance JPA reported standalone net profit of INR2.8b (down 3.3% YoY), above our estimate of INR2.4b. JPA 4QFY12 revenues stood at INR41b (up 4% YoY), while EBITDA stood at INR10b (up 32% YoY). Operating performance is driven largely by higher EPC division performance (led by margin, but lower revenues) and RE division (both higher bookings and margin). Performance of Cement division was muted. Interest cost for JPA stood at INR5.8b vs INR4.5b QoQ led by commissioning of Cement capacity. However, depreciation has come off QoQ to INR1.6b (INR2b QoQ). This led to lower PBT at INR3.1b (down 19% YoY), while lower tax/pbt ratio (9% for 4Q) arrested PAT de-growth (down 3.3% YoY). For FY12, standalone revenues stood at INR129b (flat YoY), EBIDTA of INR34.4b (up 19% YoY) and PAT of INR10.2b (up 38% YoY). Deviation in PAT is led by gain of INR2.3b of EBIDTA, INR1.6b on depreciation and lower tax of INR750m. Cement Business: volume flat YoY; realisation/ebidta improve marginally QoQ During 4QFY12, cement business revenues stood at INR17b, up 8% YoY; led by flat volumes but 6% YoY growth in realization. Volumes stood at 4.25m tons (vs 4.2m tons in 4QFY11 and 4.25m ton in 3QFY12), while realizations stood at INR3,969/ton (vs INR3,734/ton in 3QFY11 and INR3,994/ton for 3QFY12). Cement division sales for 4QFY12 were muted owing to transfer of Gujarat cement plant in Jaypee Cement - 100% subsidiary. Realisation / EBIDTA for the division was up by INR25/ton and INR82/ton QoQ. EBIDTA for the quarter thus stood at INR893/ton, higher than INR811/ton in 3QFY12 and compares with INR852/ton in 4QFY11. JPA reported INR61/ton of savings in cost on QoQ basis for the division. Higher depreciation on capacity commissioning led to flat EBIT for the division at INR2.1b, vs INR2.2b in 4QFY11. JPA's installed capacity has now increased to 33.3m tons, with the commissioning Balaji project (5m tons) on in March, JP Super Dalla (1.10mtpa) and Churk (1.50mtpa) projects are expected by 1QFY13E, taking the group's total capacity to 35.9m tons. This compares with cement capacity of 26.2m tons by March 2011 and up 4x since FY08 capacity of 9m tons. FY11 FY12 FY11 FY12 Revenues 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q Volumes (m ton) Revenues (INR m) 14,415 12,084 12,374 15,685 15,272 13,238 16,973 16,867 54,558 54,650 Realization (INR/t) 3,696 3,528 3,411 3,734 3,936 3,229 3,994 3,969 3,600 3,316 EBIT (INR m) 2,863 1,883 1,422 2,229 1,940 (295) 1,698 2,128 8,396 6,526 EBIT (INR/t) (72) EBIDTA (INR/t) 1, Source: Company/MOSL E&C business performance driven by higher margin EPC business revenues in 4QFY12 stood robust at INR17.8b (down 1% YoY) vs INR12.4b in 3QFY12. EBIT margins stood at 24% (up 12ppt YoY) due to completion of Yamuna Expressway, Karcham Wangtoo project, etc. EBIT for division stood at INR4.2b, up 94% YoY. 31 May

3 EPC division performance FY11 FY12 FY11 FY12 Revenues 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q Revenues (INR m) 14,373 15,710 12,639 17,806 12,748 15,540 12,421 17,706 60,527 58,423 EBIT (INR m) 1,048 3,279 2,706 2,185 2,500 5,458 3,707 4,232 9,267 16,054 EBIT margin (%) Source: Company/MOSL Real Estate division: beginning to witness traction again JPA booked revenues of INR5.6b from real estate business in 4QFY12, an improved given past 3 quarter of lull performance. However, EBIT from division stood at INR2.4b, translating into EBIT margin of 44%, vs 48% in 4QFY11 and 48% in 3QFY12. Real estate division performance FY11 FY12 FY11 FY12 Revenues 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q Revenues (INR m) 3,661 3,233 4,255 5,968 3,469 2,018 3,078 5,604 17,117 14,170 EBIT (INR m) 1,558 1,332 2,942 2,855 1, ,477 2,447 8,686 6,647 EBIT margin (%) Source: Company/MOSL Project commissioning to drive earnings/cashflows, focus on de-leverage JPA is set to witness increase in earnings/cashflows owing to commissioning of projects across its cement (10m tons), power (1.5GW), infrastructure (toll road project, INR133b cost) and real estate (traction in launches) business. This, would drive earnings, cashflows for the group. On standalone business, we expect EBIDTA CAGR of 12% over FY12-14E, led by improvement in cement business performance. JPA plans to consolidate operations and de-leverage using cashflows from its cement division, possible stake sale in Jaypee Cements, divestment of stake in Jaypee Infratech (83.1%), etc to lower consolidated net DER of 3.8x as at March Also, it plans to utilise RE deposits from RE bookings/launches in Jaypee Infratech to prepay INR70b debt taken for construction of Yamuna Expressway (YE) road project over next 5 years. Thus, the group's commitment would remain to equity commitment for power projects, which will be met through fund raising in JPVL itself. For FY13E, JPVL's equity commitment is expected at ~INR15-16b, where it plans to raise money through various instruments like QIP/FCCB/FPO/ Preference shares, etc (board approved fund raising of INR35b) or Sale of treasury stock (344m shares). However, the group's endeavour to diversify in other "non-core" business on continuous basis perplexes us. In FY12, JPA has invested ~INR9.5b to take over the ailing fertilizer plan at Kanpur with rated capacity of 0.7mtpa. Earlier, JPA had also diversified into development of F1 circuit, while it had announced plans to enter into milk procurement business as well (for which job opening advertisement are already listed!). In our view, constant diversification, allocation of capital into "non-core/new" area remains a risk. Valuations and view We marginally downgrade (2-4%) our earnings for JPA to factor in higher interest cost, which is partially set-off due to strong cement realisation, EPC/RE business traction. We now expect JPA to report standalone net profit of INR8.2b in FY13E (down 20% YoY) and INR11.1b in FY14E (up 37% YoY). Buy with TP of INR103/sh. 31 May

4 Jaiprakash Associates: an investment profile Company description Jaiprakash Associates (JPA) is diversified infrastructure player with presence in Cement, Power, Roads, Real Estate and Hospitality. The company is set to become third largest cement player by FY11 with target capacity of 33.5m tons, is amongst the top 10 private sector power project developer currently in terms of project under development/ pipeline (13GW) and has access to ~3.7bsf of land bank in and around NOIDA. Key investment arguments JPA plans to ramp-up cement capacity to ~35m ton by FY13E, up from 13.5m ton in FY09. Of the 13GW of power projects under development, 700MW is operational while equipment award have been placed for 3.8GW, indicating good progress. It has also begun the commissioning of 1GW of Karcham Wangtoo hydro project, beginning July JPA is an EPC contractor for the Real Estate project development at NOIDA, own power projects (~13GW), etc. This provides good revenue visibility for E&C division Key investment risks Downturn in cement business and lumpy nature of earnings Recent developments JPA has announced restructuring of the cement business with transfer of cement plants in Gujarat (4.8m tons) and Andhra Pradesh (5.0m tons) to Jaypee Cement (100% subsidiary). Jaypee Cements is also implementing capacity addition of 3m tons in Karnataka (under initial stages of construction). Local farmers have raised agitation against the ongoing Yamuna Expressway project and proposed township by UP state government. Valuations and view We now expect JPA to report standalone net profit of INR8.2b in FY13E (down 20% YoY) and INR11.1b in FY14E (up 37% YoY). Buy with TP of INR103/sh. EPS: MOSL forecast v/s consensus (INR) MOSL Consensus Variation Forecast Forecast (%) FY FY Target price and recommendation Current Target Upside Reco. Price (INR) Price (INR) (%) Buy Stock performance (1 year) Shareholding pattern (%) Mar-12 Dec-11 Mar-11 Promoter Domestic Inst Foreign Others May

5 Financials and Valuations 31 May

6 Disclosures This report is for personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained herein is based on publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, MOSt and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This report is intended for distribution to institutional investors. Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents. MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Disclosure of Interest Statement Jaiprakash Associates 1. Analyst ownership of the stock No 2. Group/Directors ownership of the stock No 3. Broking relationship with company covered No 4. Investment Banking relationship with company covered No Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues. Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions. For U.K. This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to which this document relates is only available to investment professionals and will be engaged in only with such persons. For U.S. MOSt is not a registered broker-dealer in the United States (U.S.) and, therefore, is not subject to U.S. rules. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., Motilal Oswal has entered into a chaperoning agreement with a U.S. registered broker-dealer, Marco Polo Securities Inc. ("Marco Polo"). This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, Marco Polo and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. Motilal Oswal Securities Ltd 3rd Floor, Hoechst House, Nariman Point, Mumbai Phone: reports@motilaloswal.com

NTPC CMP: INR169 TP: INR191 Buy

NTPC CMP: INR169 TP: INR191 Buy BSE SENSEX S&P CNX 18,625 5,664 Bloomberg NTPC IN Equity Shares (m) 8,245.5 52-Week Range (INR) 190/139 1,6,12 Rel. Perf. (%) 3/-4/-11 M.Cap. (INR b) 1,393.5 M.Cap. (USD b) 26.0 26 October 2012 2QFY13

More information

Reliance Infrastructure CMP: INR528

Reliance Infrastructure CMP: INR528 BSE SENSEX S&P CNX 17,657 5,363 16 August 2012 1QFY13 Results Update Sector: Utilities Reliance Infrastructure CMP: INR528 Buy Bloomberg RELI IN Equity Shares (m) 267.5 52-Week Range (INR) 680/328 1,6,12

More information

Coal India CMP: INR348 TP: INR408 Buy

Coal India CMP: INR348 TP: INR408 Buy BSE SENSEX S&P CNX 17,633 5,348 Bloomberg COAL IN Equity Shares (m) 6,316.4 52-Week Range (INR) 404/294 1,6,12 Rel. Perf. (%) -4/4/-15 M.Cap. (INR b) 2,198.1 M.Cap. (USD b) 39.7 14 August 2012 1QFY13 Results

More information

BGR Energy. CMP: INR284 TP: INR296 Neutral

BGR Energy. CMP: INR284 TP: INR296 Neutral BSE SENSEX S&P CNX 16,312 4,951 Bloomberg BGRL IN Equity Shares (m) 72.0 52-Week Range (INR) 512/173 1,6,12 Rel. Perf. (%) -8/8/-31 M.Cap. (INR b) 20.5 M.Cap. (USD b) 0.4 31 May 2012 4QFY12 Results Update

More information

Larsen & Toubro. CMP: INR1,160 TP: INR1,417 Buy

Larsen & Toubro. CMP: INR1,160 TP: INR1,417 Buy BSE SENSEX S&P CNX 16,216 4,908 Bloomberg LT IN Equity Shares (m) 608.9 52-Week Range (INR) 1,868/971 1,6,12 Rel. Perf. (%) -4/-7/12 M.Cap. (INR b) 706.3 M.Cap. (USD b) 13.1 * Consolidated; EPS is fully

More information

BGR Energy. CMP: INR282 TP: INR253 Neutral

BGR Energy. CMP: INR282 TP: INR253 Neutral BSE SENSEX S&P CNX 17,413 5,283 Bloomberg BGRL IN Equity Shares (m) 72.0 52-Week Range (INR) 378/173 1,6,12 Rel. Perf. (%) -9/17/-22 M.Cap. (INR b) 20.3 M.Cap. (USD b) 0.4 6 August 2012 1QFY13 Results

More information

Unitech. CMP: INR20 TP: INR30 Buy

Unitech. CMP: INR20 TP: INR30 Buy BSE SENSEX S&P CNX 16,328 4,943 Bloomberg UT IN Equity Shares (m) 2,438.8 52-Week Range (INR) 38/17 1,6,12 Rel. Perf. (%) -25/-14/-34 M.Cap. (INR b) 48.8 M.Cap. (USD b) 0.9 16 May 2012 4QFY12 Results Update

More information

IndusInd Bank. CMP: INR345 TP: INR419 Buy

IndusInd Bank. CMP: INR345 TP: INR419 Buy BSE SENSEX S&P CNX 17,504 5,332 Bloomberg IIB IN Equity Shares (m) 467.7 52-Week Range (INR) 352/222 1,6,12 Rel.Perf.(%) 13/25/34 M.Cap. (INR b) 161.4 M.Cap. (USD b) 3.1 20 April 2012 4QFY12 Results Update

More information

Punjab National Bank. CMP:INR1,103 TP:INR1,500 Buy

Punjab National Bank. CMP:INR1,103 TP:INR1,500 Buy BSE SENSEX S&P CNX 18,210 5,488 28 July 2011 1QFY12 Results Update Sector: Banking Punjab National Bank CMP:INR1,103 TP:INR1,500 Buy Bloomberg PNB IN Equity Shares (m) 316.8 52-Week Range (INR) 1,395/971

More information

Pidilite Industries. CMP: INR164 TP: INR186 Buy

Pidilite Industries. CMP: INR164 TP: INR186 Buy BSE SENSEX S&P CNX 16,640 5,043 Bloomberg PIDI IN Equity Shares (m) 506.1 52-Week Range (INR) 188/134 1,6,12 Rel. Perf. (%) 1/20/5 M.Cap. (INR b) 83.0 M.Cap. (USD b) 1.5 27 July 2012 1QFY13 Results Update

More information

CMP: INR121 TP: INR193 Buy

CMP: INR121 TP: INR193 Buy BSE SENSEX S&P CNX 17,085 5,139 20 October 2011 2QFY12 Results Update Sector: Metals Hindustan Zinc CMP: INR121 TP: INR193 Buy Bloomberg HZ IN Equity Shares (m) 4,225.3 52-Week Range (INR) 155/109 1,6,12

More information

Asian Paints. CMP: INR2,722 TP: INR3,161 Buy

Asian Paints. CMP: INR2,722 TP: INR3,161 Buy BSE SENSEX S&P CNX 16,739 5,049 Bloomberg APNT IN Equity Shares (m) 95.9 52-Week Range (INR) 3,366/2,395 1,6,12 Rel. Perf. (%) -5/-3/14 M.Cap. (INR b) 261.1 M.Cap. (USD b) 4.9 23 January 2012 3QFY12 Results

More information

Larsen & Toubro. CMP: INR1,278 TP: INR1,380 Buy

Larsen & Toubro. CMP: INR1,278 TP: INR1,380 Buy BSE SENSEX S&P CNX 16,786 5,050 Bloomberg LT IN Equity Shares (m) 608.9 52-Week Range (INR) 1,933/971 1,6,12 Rel. Perf. (%) 20/-19/-11 M.Cap. (INR b) 778.1 M.Cap. (USD b) 15.5 * Consolidated; EPS is fully

More information

Canara Bank. CMP: INR419 TP: INR525 Buy

Canara Bank. CMP: INR419 TP: INR525 Buy BSE SENSEX S&P CNX 18,817 5,724 Bloomberg CBK IN Equity Shares (m) 443.0 52-Week Range (INR) 566/349 1,6, 12 Rel.Perf.(%) -7/-18/-17 M.Cap. (INR b) 170.3 M.Cap. (USD b) 3.0 7 November 2012 2QFY13 Results

More information

Tata Power. CMP: INR111 TP: INR92 Neutral

Tata Power. CMP: INR111 TP: INR92 Neutral BSE SENSEX S&P CNX 17,749 5,382 Bloomberg TPWR IN Equity Shares (m) 2,373.3 52-Week Range (INR) 135/81 1,6,12 Rel. Perf. (%) 10/-5/-10 M.Cap. (INR b) 263.9 M.Cap. (USD b) 5.3 13 February 2012 3QFY12 Results

More information

BGR Energy. CMP: INR266 TP: INR230 Neutral

BGR Energy. CMP: INR266 TP: INR230 Neutral BSE SENSEX S&P CNX 18,562 5,645 Bloomberg BGRL IN Equity Shares (m) 72.0 52-Week Range (INR) 374/173 1,6,12 Rel. Perf. (%) -3/27/-24 M.Cap. (INR b) 19.2 M.Cap. (USD b) 0.4 3 November 2012 2QFY13 Results

More information

Titan Industries. CMP: INR222 TP: INR220 Neutral

Titan Industries. CMP: INR222 TP: INR220 Neutral BSE SENSEX S&P CNX 17,257 5,241 Bloomberg TTAN IN Equity Shares (m) 887.8 52-Week Range (INR) 255/154 1,6,12 Rel. Perf. (%) -1/13/3 M.Cap. (Rs b) 197.1 M.Cap. (US$ b) 3.6 2 August 2012 1QFY13 Results Update

More information

Jubilant Foodworks. CMP: INR1,189 TP: INR1,0541,054 Neutral

Jubilant Foodworks. CMP: INR1,189 TP: INR1,0541,054 Neutral BSE SENSEX S&P CNX 16,846 5,110 Bloomberg JUBI IN Equity Shares (m) 63.5 52-Week Range (INR) 1,189/633 1,6,12 Rel. Perf. (%) 4/38/47 M.Cap. (INR b) 75.5 M.Cap. (USD b) 1.3 26 July 2012 1QFY13 Results Update

More information

Godawari Power & Ispat

Godawari Power & Ispat BSE SENSEX S&P CNX CMP: INR103 TP: INR185 Buy 17,077 5,158 Bloomberg GODPI IN Equity Shares (m) 31.8 52-Week Range (INR) 200/70 1,6,12 Rel. Perf. (%) 32/-31/-33 M.Cap. (INR b) 3.3 M.Cap. (USD m) 65.3 Consolidated

More information

CMP: INR350 TP: INR375 Downgrade to Neutral

CMP: INR350 TP: INR375 Downgrade to Neutral BSE Sensex S&P CNX 19,497 5,897 Bloomberg COAL IN Equity Shares (m) 6,316.4 M.Cap. (INR b)/(usd b) 2,211/41 52-Week Range (INR) 386/301 1,6,12 Rel. Perf. (%) 1/-11/-5 Financials & Valuation (INR b) Y/E

More information

IDBI Bank. CMP: INR106 TP: INR121 Neutral

IDBI Bank. CMP: INR106 TP: INR121 Neutral BSE SENSEX S&P CNX 17,207 5,223 Bloomberg IDBI IN Equity Shares (m) 1,278.4 52-Week Range (INR) 154/77 1,6,12 Rel.Perf.(%) -1/0/-7 M.Cap. (INR b) 135.5 M.Cap. (USD b) 2.6 24 April 2012 4QFY12 Results Update

More information

Petronet LNG. CMP: INR146 TP: INR205 Buy

Petronet LNG. CMP: INR146 TP: INR205 Buy BSE SENSEX S&P CNX 17,236 5,229 Bloomberg PLNG IN Equity Shares (m) 750.0 52-Week Range (INR) 186/122 1,6,12 Rel. Perf. (%) 3/-11/-10 M.Cap. (INR b) 109.7 M.Cap. (USD b) 2.0 1 August 2012 1QFY13 Results

More information

Hardick Bora

Hardick Bora BSE Sensex S&P CNX 19,990 6,069 Bloomberg JOL IN Equity Shares (m) 159.3 M.Cap. (INR b)/(usd b) 26.0/0.5 52-Week Range (INR) 248/154 1,6,12 Rel. Perf. (%) -18/-28/-34 Financials & Valuation (INR b) Y/E

More information

Cummins India. CMP: INR430 TP: INR462 Neutral

Cummins India. CMP: INR430 TP: INR462 Neutral BSE SENSEX S&P CNX 16,070 4,870 Bloomberg KKC IN Equity Shares (m) 277.2 52-Week Range (INR) 515/322 1,6,12 Rel. Perf. (%) -3/30/-4 M.Cap. (INR b) 119.2 M.Cap. (USD b) 2.2 17 May 2012 4QFY12 Results Update

More information

Idea Cellular. CMP: INR81 TP: INR Under Review

Idea Cellular. CMP: INR81 TP: INR Under Review BSE SENSEX S&P CNX 16,918 5,128 Bloomberg IDEA IN Equity Shares (m) 3,308.8 52-Week Range (INR) 104/71 1,6,12 Rel. Perf. (%) 6/-13/4 M.Cap. (INR b) 268.0 M.Cap. (USD b) 4.8 25 July 2012 1QFY13 Results

More information

Canara Bank. CMP: INR464 TP: INR645 Buy

Canara Bank. CMP: INR464 TP: INR645 Buy BSE SENSEX S&P CNX 17,234 5,205 Bloomberg CBK IN Equity Shares (m) 443.0 52-Week Range (INR) 672/349 1,6, 12 Rel.Perf.(%) 22/2/-13 M.Cap. (INR b) 205.6 M.Cap. (USD b) 4.1 31 January 2012 3QFY12 Results

More information

Kotak Mahindra Bank. CMP: INR495 TP: INR429 Neutral

Kotak Mahindra Bank. CMP: INR495 TP: INR429 Neutral BSE SENSEX S&P CNX 16,739 5,049 Bloomberg KMB IN Equity Shares (m) 689.3 52-Week Range 515/333 1,6,12 Rel.Perf.(%) 0/12/31 M.Cap. (Rs b) 340.5 M.Cap. (US$ b) 6.7 25 January 2012 3QFY12 Results Update Sector:

More information

Punjab National Bank. CMP: INR716 TP: INR950 Buy

Punjab National Bank. CMP: INR716 TP: INR950 Buy BSE SENSEX S&P CNX 16,839 5,100 Bloomberg PNB IN Equity Shares (m) 339.2 52-Week Range (INR) 1,144/703 1,6,12 Rel.Perf.(%) -8/-24/-28 M.Cap. (INR b) 242.8 M.Cap. (USD b) 4.4 30 July 2012 1QFY13 Results

More information

Niket Shah

Niket Shah BSE Sensex S&P CNX 20,213 6,147 Bloomberg VGRD IN Equity Shares (m) 29.8 M.Cap. (INR b)/(usd b) 14.6/0.3 52-Week Range (INR) 591/180 1,6,12 Rel. Perf. (%) -8/-6/138 Financial summary (INR b) Y/E March

More information

Godrej Consumer Products

Godrej Consumer Products BSE SENSEX S&P CNX 17,602 5,337 Bloomberg GCPL IN Equity Shares (m) 340.3 52-Week Range (INR) 658/370 1,6,12 Rel. Perf. (%) 5/37/42 M.Cap. (INR b) 205.9 M.Cap. (USD b) 3.7 7 August 2012 1QFY13 Results

More information

Shree Renuka Sugars. CMP: INR26 TP: INR45 Buy

Shree Renuka Sugars. CMP: INR26 TP: INR45 Buy BSE SENSEX S&P CNX 16,219 4,924 1 June 2012 6QSY12 Results Update Sector: Sugar CMP: INR26 TP: INR45 Buy Bloomberg SHRS IN Equity Shares (m) 671.0 52-Week Range (INR) 76/23 1,6,12 Rel. Perf. (%) -10/-16/-45

More information

Monnet Ispat. CMP: INR449 TP: INR518 Neutral

Monnet Ispat. CMP: INR449 TP: INR518 Neutral 4QFY12 Results Update Sector: Metals Monnet Ispat BSE SENSEX S&P CNX 16,328 4,943 CMP: INR449 TP: INR518 Neutral Bloomberg MISP IN Equity Shares (m) 64.4 52-Week Range (INR) 561/305 1,6,12 Rel. Perf. (%)

More information

Sanofi India. CMP: INR2,200 TP: INR1,848 Neutral

Sanofi India. CMP: INR2,200 TP: INR1,848 Neutral BSE SENSEX S&P CNX 16,846 5,110 Bloomberg SANL IN Equity Shares (m) 23.0 52-Week Range (INR) 2,430/1,980 1,6,12 Rel. Perf. (%) 3/-3/15 M.Cap. (INR b) 50.7 M.Cap. (USD b) 0.9 26 July 2012 2QCY12 Results

More information

Sohail Halai Alpesh Mehta

Sohail Halai Alpesh Mehta BSE Sensex S&P CNX 20,039 6,064 Bloomberg IDBI IN Equity Shares (m) 1,278.4 M.Cap. (INR b)/(usd b) 144.9/2.7 52-Week Range (INR) 122/82 1,6,12 Rel.Perf.(%) -1/6/2 Financials & Valuation (INR b) Y/E March

More information

Sanjay Jain Pavas Pethia

Sanjay Jain Pavas Pethia BSE Sensex S&P CNX 19,561 5,923 Bloomberg SAIL IN Equity Shares (m) 4,130.4 M.Cap. (INR b)/(usd b) 334.6/6.2 52-Week Range (INR) 116/76 1,6,12 Rel. Perf. (%) -11/-17/-38 Financials & Valuation (INR b)

More information

Punjab National Bank. CMP: INR768 TP: INR963 Buy

Punjab National Bank. CMP: INR768 TP: INR963 Buy BSE SENSEX S&P CNX 16,480 4,975 Bloomberg PNB IN Equity Shares (m) 339.2 52-Week Range (INR) 1,200/751 1,6,12 Rel.Perf.(%) -12/-16/-18 M.Cap. (INR b) 260.5 M.Cap. (USD b) 4.8 10 May 2012 4QFY12 Results

More information

Jubilant Foodworks. CMP: INR1,051 TP: INR1,054 Neutral

Jubilant Foodworks. CMP: INR1,051 TP: INR1,054 Neutral BSE SENSEX S&P CNX 16,420 4,966 Bloomberg JUBI IN Equity Shares (m) 63.5 52-Week Range (INR) 1,144/536 1,6,12 Rel. Perf. (%) -6/37/53 M.Cap. (INR b) 66.7 M.Cap. (USD b) 1.3 11 May 2012 4QFY12 Results Update

More information

Strides Arcolab. CMP: INR717 TP: INR829 Buy

Strides Arcolab. CMP: INR717 TP: INR829 Buy BSE SENSEX S&P CNX 17,144 5,200 Bloomberg STR IN Equity Shares (m) 57.7 52-Week Range (INR) 794/276 1,6,12 Rel. Perf. (%) -2/37/98 M.Cap. (INR b) 41.4 M.Cap. (USD b) 0.7 31 July 2012 2QCY12 Results Update

More information

Steel Authority of India

Steel Authority of India BSE SENSEX S&P CNX 16,439 4,990 4QFY12 Results Update Sector: Metals Steel Authority of India CMP: INR93 TP: INR99 Sell Bloomberg SAIL IN Equity Shares (m) 4,130.4 52-Week Range (INR) 151/73 1,6,12 Rel.

More information

Axis Bank. CMP: INR1,008 TP: INR1,240 Buy

Axis Bank. CMP: INR1,008 TP: INR1,240 Buy BSE SENSEX S&P CNX 16,739 5,049 Bloomberg AXSB IN Equity Shares (m) 410.5 52-Week Range 1,461/785 1,6,12 Rel.Perf.(%) 11/-9/-9 M.Cap. (INR b) 413.8 M.Cap. (USD b) 8.2 20 January 2012 Results Update Sector:

More information

Dabur India. CMP: INR106 TP: INR94 Neutral

Dabur India. CMP: INR106 TP: INR94 Neutral 28 July 2011 1QFY12 Results Update Sector: FMCG BSE SENSEX S&P CNX 18,210 5,488 Dabur India CMP: INR106 TP: INR94 Neutral Bloomberg DABUR IN Equity Shares (m) 1,740.0 52-Week Range (INR) 122/87 1,6,12

More information

Coal India. CMP: INR322 TP: INR370 Buy

Coal India. CMP: INR322 TP: INR370 Buy BSE SENSEX S&P CNX 16,439 4,990 Bloomberg COAL IN Equity Shares (m) 6,316.4 52-Week Range (INR) 422/294 1,6,12 Rel. Perf. (%) -4/-3/-7 M.Cap. (INR b) 2,033.9 M.Cap. (USD b) 36.4 30 May 2012 4QFY12 Results

More information

Punjab National Bank. CMP: INR940 TP: INR1,275 Buy

Punjab National Bank. CMP: INR940 TP: INR1,275 Buy BSE SENSEX S&P CNX 17,194 5,199 Bloomberg PNB IN Equity Shares (m) 316.8 52-Week Range (INR) 1,234/751 1,6,12 Rel.Perf.(%) 9/-10/-9 M.Cap. (INR b) 297.7 M.Cap. (USD b) 6.0 1 February 2012 3QFY12 Results

More information

Axis Bank. CMP: INR1,119 TP: INR1,330 Buy

Axis Bank. CMP: INR1,119 TP: INR1,330 Buy BSE SENSEX S&P CNX 18,714 5,687 Bloomberg AXSB IN Equity Shares (m) 413.2 52-Week Range (INR) 1,309/785 1,6,12 Rel.Perf.(%) 9/-16/-8 M.Cap. (INR b) 462.4 M.Cap. (USD b) 8.7 16 October 2012 2QFY13 Results

More information

Cement. Demand to grow 8%, with cost push to be passed on CCI probe to have limited impact

Cement. Demand to grow 8%, with cost push to be passed on CCI probe to have limited impact 15 May 2012 Update Cement Demand to grow 8%, with cost push to be passed on CCI probe to have limited impact We met with senior managements of the large cement companies in India, to get perspective on

More information

Hindalco. CMP: INR113 TP: INR151 Buy

Hindalco. CMP: INR113 TP: INR151 Buy BSE SENSEX S&P CNX 18,817 5,724 Bloomberg HNDL IN Equity Shares (m) 1,990.0 52-Week Range (INR) 165/100 1,6,12 Rel. Perf. (%) -9/-18/-26 M.Cap. (INR b) 224.9 M.Cap. (USD b) 4.1 Consolidated 2QFY13 Results

More information

CMP: INR415 TP: INR 471 BUY

CMP: INR415 TP: INR 471 BUY 04 Mar 2013 Update Sector: Technology Wipro CMP: INR415 TP: INR 471 BUY Pipeline and deal signings suggest improvement in growth; Multiple levers and focus on productivity will cushion margin headwinds

More information

JSW Steel. CMP: INR670 TP: INR391 Sell Merger with JSW Ispat

JSW Steel. CMP: INR670 TP: INR391 Sell Merger with JSW Ispat BSE SENSEX S&P CNX 17,384 5,254 Bloomberg JSTL IN Equity Shares (m) 223.1 52-Week Range (INR) 885/464 1,6,12 Rel. Perf. (%) -5/-12/-10 M.Cap. (INR b) 149.5 M.Cap. (USD b) 2.7 Valuation summary (INR b)

More information

Kotak Mahindra Bank. CMP: INR626 TP: INR500 Neutral

Kotak Mahindra Bank. CMP: INR626 TP: INR500 Neutral BSE SENSEX S&P CNX 18,759 5,705 Bloomberg KMB IN Equity Shares (m) 740.7 52-Week Range (INR) 652/418 1,6,12 Rel.Perf.(%) -3/-2/18 M.Cap. (INR b) 463.4 M.Cap. (USD b) 8.6 26 October 2012 2QFY13 Results

More information

Jaypee Infratech. CMP: INR33 TP: INR45 Buy

Jaypee Infratech. CMP: INR33 TP: INR45 Buy BSE SENSEX S&P CNX 2,550,318 Bloomberg JPIN IN Equity Shares (m) 1,388.9 M.Cap. (INR b) / (USD b) 51.3/0.9 52-Week Range (INR) 2/1 1,, 12 Rel. Per (%) 1/9/-3 Financials & Valuation (INR m) Y/E Mar 201

More information

Jinesh Gandhi Sandipan Pal

Jinesh Gandhi Sandipan Pal BSE Sensex S&P CNX 20,224 6,157 Bloomberg BCORP IN Equity Shares (m) 77.0 M.Cap. (INR b)/(usd b) 20.5/0.4 52-Week Range (INR) 342/202 1,6,12 Rel. Perf. (%) 6/-15/-23 Financials & Valuation (INR b) Y/E

More information

Idea Cellular. CMP: INR159 TP: INR200 Buy

Idea Cellular. CMP: INR159 TP: INR200 Buy BSE SENSEX S&P CNX 19,164 5,678 Bloomberg IDEA IN Equity Shares (m) 3,316.2 M.Cap. (INR b) / (USD b) 513.7/8.4 52-Week Range (INR) 176/72 1, 6, 12 Rel. Per (%) 12/45/83 Financials & Valuation (INR Billion)

More information

BHEL. CMP: INR227 TP: INR233 Neutral

BHEL. CMP: INR227 TP: INR233 Neutral BSE SENSEX S&P CNX 18,636 5,666 Bloomberg BHEL IN Equity Shares (m) 2,447.6 52-Week Range (INR) 368/198 1,6,12 Rel. Perf. (%) -7/-7/-35 M.Cap. (INR b) 556.2 M.Cap. (USD b) 10.3 30 October 2012 2QFY13 Results

More information

M&M Financial Services

M&M Financial Services BSE SENSEX S&P CNX 18,793 5,717 Bloomberg MMFS IN Equity Shares (m) 102.7 52-Week Range (INR) 938/590 1,6,12 Rel.Perf.(%) 7/24/30 M.Cap. (INR b) 90.7 M.Cap. (USD b) 1.7 23 October 2012 2QFY13 Results Update

More information

Godrej Properties. CMP: INR595 TP: INR635 Neutral

Godrej Properties. CMP: INR595 TP: INR635 Neutral BSE SENSEX S&P CNX 16,913 5,114 Bloomberg GPL IN Equity Shares (m) 78.0 52-Week Range 845/570 1,6,12 Rel. Perf. (%) 0/-9/-2 M.Cap. (INR b) 46.4 M.Cap. (USD b) 0.9 4QFY12 Results Update Sector: Real Estate

More information

Pantaloon Retail. CMP: INR177 TP: INR192 Neutral

Pantaloon Retail. CMP: INR177 TP: INR192 Neutral BSE SENSEX S&P CNX 17,773 5,390 Bloomberg PF IN Equity Shares (m) 217.1 52-Week Range (INR) 364/125 1,6,12 Rel. Perf. (%) 9/-49/-29 M.Cap. (Rs b) 38.4 M.Cap. (US$ b) 0.8 14 February 2012 2QFY12 Results

More information

Hindustan Unilever. CMP:INR324 TP:INR302 Neutral

Hindustan Unilever. CMP:INR324 TP:INR302 Neutral BSE SENSEX S&P CNX 18,197 5,482 29 July 2011 1QFY12 Results Update Sector: FMCG Hindustan Unilever CMP:INR324 TP:INR302 Neutral Bloomberg HUVR IN Equity Shares (m) 2,159.5 52-Week Range (INR) 347/250 1,6,12

More information

Raymond. Restructuring initiatives bearing fruit; Land bank base case value INR147/share; Reiterate Buy. CMP: INR385 TP: INR462 Buy

Raymond. Restructuring initiatives bearing fruit; Land bank base case value INR147/share; Reiterate Buy. CMP: INR385 TP: INR462 Buy 14 June 2012 Update Raymond CMP: INR385 TP: INR462 Buy Restructuring initiatives bearing fruit; Land bank base case value INR147/share; Reiterate Buy We met the management of Raymond (RW IN, Mkt Cap USD0.4b,

More information

Tribhovandas Bhimji Zaveri

Tribhovandas Bhimji Zaveri 24 April 2012 Update CMP INR TP INR TRIBHOVANDAS BHIMJI ZAVERI Pure jewellery retail play with strong brand; Execution risks priced in; Subscribe (TBZ) is a pure play on the fast-growing branded jewellery

More information

Shree Renuka Sugars. CMP: INR41 TP: INR50 Buy

Shree Renuka Sugars. CMP: INR41 TP: INR50 Buy BSE SENSEX S&P CNX 18,202 5,532 Bloomberg SHRS IN Equity Shares (m) 671.0 52-Week Range (INR) 87/23 1,6,12 Rel. Perf. (%) 14/-39/-51 M.Cap. (INR b) 27.3 M.Cap. (USD b) 0.6 16 February 2012 5QSY12 Results

More information

Oberoi Realty. CMP: INR264 TP: INR315 Buy

Oberoi Realty. CMP: INR264 TP: INR315 Buy BSE SENSEX S&P CNX 17,151 5,202 Bloomberg OBER IN Equity Shares (m) 328.2 52-Week Range (INR) 323/205 1,6,12 Rel. Perf. (%) 4/15/16 M.Cap. (INR b) 87.0 M.Cap. (USD b) 1.7 26 April 2012 4QFY12 Results Update

More information

Thermax. CMP: INR522 TP: INR414 Neutral

Thermax. CMP: INR522 TP: INR414 Neutral BSE SENSEX S&P CNX 17,605 5,326 Bloomberg TMX IN Equity Shares (m) 119.2 52-Week Range (INR) 720/388 1,6,12 Rel. Perf. (%) 14/1/-21 M.Cap. (INR b) 60.3 M.Cap. (USD b) 1.1 3 February 2012 3QFY12 Results

More information

Siddharth Bothra

Siddharth Bothra BSE Sensex S&P CNX 19,152 5,797 Bloomberg CSTRL IN Equity Shares (m) 494.6 M.Cap. (INR b)/(usd b) 158/2.9 52-Week Range (INR) 338/223 1,6,12 Rel. Perf. (%) 12/-3/26 Financials & Valuation (INR b) Y/E March

More information

Hardick Bora 4QCY12 Results Update Sector: Healthcare Sanofi India CMP: INR2,307 TP: INR2,015 Neutral

Hardick Bora 4QCY12 Results Update Sector: Healthcare Sanofi India CMP: INR2,307 TP: INR2,015 Neutral BSE Sensex S&P CNX 19,332 5,855 Bloomberg SANL IN Equity Shares (m) 23.0 M.Cap. (INR b)/(usd b) 53.1/1.0 52-Week Range (INR) 2,450/2,002 1,6,12 Rel. Perf. (%) 9/-1/-4 Financials & Valuation (INR b) Y/E

More information

Jinesh Gandhi Chirag Jain

Jinesh Gandhi Chirag Jain BSE Sensex S&P CNX 19,561 5,923 Bloomberg EIM IN Equity Shares (m) 27.0 M.Cap. (INR b)/(usd b) 72.0/1.3 52-Week Range 3,240/1,620 1,6,12 Rel. Perf. (%) -4/17/40 Financials & Valuation (INR b) Y/E Dec 2013E

More information

Sandipan Pal QFY13 Results Update Sector: Real Estate Unitech CMP: INR29 TP: INR44 Buy

Sandipan Pal QFY13 Results Update Sector: Real Estate Unitech CMP: INR29 TP: INR44 Buy BSE Sensex S&P CNX 19,608 5,933 Bloomberg UT IN Equity Shares (m) 2,438.8 M.Cap. (INR b)/(usd b) 70/1.3 52-Week Range (INR) 41/18 1,6,12 Rel. Perf. (%) -27/24/-13 Financials & Valuation (INR b) Y/E March

More information

Maruti Suzuki. CMP: INR1,395 TP: INR1,730 Buy

Maruti Suzuki. CMP: INR1,395 TP: INR1,730 Buy BSE SENSEX S&P CNX 18,431 5,598 Bloomberg MSIL IN Diluted Equity Shares (m) 302.1 52-Week Range (INR) 1,498/906 1,6,12 Rel.Perf.(%) 5/-5/20 M.Cap. (INR b) 421.3 M.Cap. (USD b) 7.8 31 October 2012 2QFY13

More information

Urban demand revives; Akzo gaining market share

Urban demand revives; Akzo gaining market share BSE Sensex S&P CNX 22,095 6,601 CMP: INR889 26 March 2014 Update Sector: Consumer Not Rated Urban demand revives; Akzo gaining market share Reiterates focus on Profitable growth Urban demand for Decorative

More information

Phoenix Mills. CMP: INR184 TP: INR255 Buy

Phoenix Mills. CMP: INR184 TP: INR255 Buy BSE SENSEX S&P CNX 16,439 4,990 Bloomberg PHNX IN Equity Shares (m) 144.8 52-Week Range (INR) 229/149 1,6,12 Rel. Perf. (%) -8/-5/10 M.Cap. (INR b) 26.8 M.Cap. (USD b) 0.5 30 May 2012 4QFY12 Results Update

More information

Dabur India. CMP: INR130 TP: INR135 Neutral

Dabur India. CMP: INR130 TP: INR135 Neutral BSE SENSEX S&P CNX 18,625 5,664 29 October 2012 2QFY13 Results Update Sector: Consumer Dabur India CMP: INR130 TP: INR135 Neutral Bloomberg DABUR IN Equity Shares (m) 1,740.7 52-Week Range (Rs) 139/92

More information

Sun Pharmaceuticals. CMP: INR554 TP: INR614 Neutral

Sun Pharmaceuticals. CMP: INR554 TP: INR614 Neutral BSE SENSEX S&P CNX 17,849 5,416 Bloomberg SUNP IN Equity Shares (m) 1,035.6 52-Week Range (INR) 566/404 1,6,12 Rel. Perf. (%) -3/10/31 M.Cap. (INR b) 573.7 M.Cap. (USD b) 11.6 15 February 2012 3QFY12 Results

More information

Godrej Consumer Products

Godrej Consumer Products BSE SENSEX S&P CNX 18,755 5,698 Bloomberg GCPL IN Equity Shares (m) 340.3 52-Week Range (INR) 745/370 1,6,12 Rel. Perf. (%) 4/17/67 M.Cap. (INR b) 246.4 M.Cap. (USD b) 4.6 5 November 2012 2QFY13 Results

More information

Alpesh Mehta Sohail Halai

Alpesh Mehta Sohail Halai BSE Sensex S&P CNX 19,664 5,969 Bloomberg IIB IN Equity Shares (m) 521.8 M. Cap. (INR b)/(usd b) 227/4.1 52-Week Range (INR) 441/242 1,6,12 Rel.Perf.(%) 3/15/52 Financials & Valuation (INR b) Y/E March

More information

Stress test: Weak capital servicing ratios to drive pricing discipline

Stress test: Weak capital servicing ratios to drive pricing discipline Stress test: Weak capital servicing ratios to drive pricing discipline Operating performance near trough; expect gradual improvement 20 Update Cement Our analysis of a cross-section of cement companies

More information

Market share recovery, price hike, content leverage to drive growth

Market share recovery, price hike, content leverage to drive growth BSE Sensex S&P CNX 24,377 7,276 Stock Info Bloomberg DITV IN Equity Shares (m) 1,064.8 52-Week Range (INR) 71/40 1, 6, 12 Rel. Per (%) 6/-15/-41 M.Cap. (INR b) 58.2 M.Cap. (USD b) 1.0 Financial Snapshot

More information

ITC. CMP: INR201 TP: INR230 Buy

ITC. CMP: INR201 TP: INR230 Buy BSE SENSEX S&P CNX 16,739 5,049 Bloomberg ITC IN Equity Shares (m) 7,738.1 52-Week Range (INR) 211/149 1,6,12 Rel. Perf. (%) 3/23/38 M.Cap. (INR b) 1,601.0 M.Cap. (USD b) 32.1 21 January 2012 Results Update

More information

CPCB-2: Important long-term driver

CPCB-2: Important long-term driver BSE Sensex S&P CNX 20,860 6,217 19 December 2013 Update Sector: Capital Goods Cummins India CMP: INR461 TP: INR540 Buy Stock Info Bloomberg KKC IN Equity Shares (m) 277.2 52-Week Range (INR) 550/365 1,

More information

Birla Corporation. CMP: INR216 TP: INR277 Buy

Birla Corporation. CMP: INR216 TP: INR277 Buy BSE SENSEX S&P CNX 16,839 5,100 Bloomberg BCORP IN Equity Shares (m) 77.0 52-Week Range (INR) 348/211 1,6,12 Rel. Perf. (%) -5/-19/-25 M.Cap. (INR b) 16.6 M.Cap. (USD b) 0.3 30 July 2012 1QFY13 Results

More information

Oberoi Realty. CMP: INR269 TP: INR320 Buy

Oberoi Realty. CMP: INR269 TP: INR320 Buy BSE SENSEX S&P CNX 18,682 5,684 Bloomberg OBER IN Equity Shares (m) 328.2 52-Week Range (INR) 323/205 1,6,12 Rel. Perf. (%) 13/-7/7 M.Cap. (INR b) 88.3 M.Cap. (USD b) 1.6 22 October 2012 2QFY13 Results

More information

Cross service charges at INR m/quarter

Cross service charges at INR m/quarter BSE SENSEX S&P CNX 19,636 5,940 Cummins India CMP: INR504 TP: INR585 Buy LHP products to be an important growth driver Cross service charges at INR100-200m/quarter 20 February 2013 Update Sector: Capital

More information

CMP: INR401 TP: INR516 Buy. * After ESOP charges; # Axon consolidated in December 2008

CMP: INR401 TP: INR516 Buy. * After ESOP charges; # Axon consolidated in December 2008 19 October 2011 1QFY12 Results Update Sector: Technology BSE SENSEX S&P CNX 16,748 5,038 Bloomberg HCLT IN Equity Shares (m) 700.9 52-Week Range (INR) 528/360 1,6,12 Rel. Perf. (%) 4/-1/7 M.Cap. (INR b)

More information

Hardick Bora QFY13 Results Update Sector: Healthcare Lupin CMP: INR725 TP: INR851 Buy

Hardick Bora QFY13 Results Update Sector: Healthcare Lupin CMP: INR725 TP: INR851 Buy BSE Sensex S&P CNX 19,990 6,069 Bloomberg LPC IN Equity Shares (m) 447.6 M.Cap. (INR b)/(usd b) 324.5/6.0 52-Week Range (INR) 739/507 1,6,12 Rel. Perf. (%) 9/18/13 Financials & Valuation (INR b) Y/E March

More information

Previous Recommendation: Buy

Previous Recommendation: Buy 2QCY10 Results Update SECTOR: CEMENT ACC STOCK INFO. BSE Sensex: 18,113 S&P CNX: 5,442 BLOOMBERG ACC IN REUTERS CODE ACC.BO Previous Recommendation: Buy Buy Rs816 Equity Shares (m) 187.9 52-Week Range

More information

Jinesh Gandhi Chirag Jain

Jinesh Gandhi Chirag Jain BSE Sensex S&P CNX 19,722 5,995 Bloomberg EIM IN Equity Shares (m) 27.0 M.Cap. (INR b)/(usd b) 88.1/1.6 52-Week Range (INR) 3,285/1,620 1,6,12 Rel. Perf. (%) 10/20/36 Financials & Valuation (INR b) Y/E

More information

Maruti Suzuki. CMP:Rs1,327 TP:Rs1,625 Buy

Maruti Suzuki. CMP:Rs1,327 TP:Rs1,625 Buy 25 April 2011 4QFY11 Results Update Sector: Automobiles Maruti Suzuki BSE SENSEX S&P CNX 19,584 5,875 Bloomberg MSIL IN Diluted Equity Shares (m) 289.0 52-Week Range (Rs) 1,600/1,126 1,6,12 Rel.Perf.(%)

More information

Godrej Consumer Products

Godrej Consumer Products BSE SENSEX S&P CNX 16,739 5,049 Bloomberg GCPL IN Equity Shares (m) 323.6 52-Week Range (INR) 464/325 1,6,12 Rel. Perf. (%) 3/3/16 M.Cap. (INR b) 135.6 M.Cap. (USD b) 2.7 24 January 2012 3QFY12 Results

More information

Just Dial. CMP: INR1,129 TP: INR1,475 Buy

Just Dial. CMP: INR1,129 TP: INR1,475 Buy BSE SENSEX S&P CNX 23,871 7,109 Bloomberg JUST IN Equity Shares (m) 70.2 M.Cap. (INR b) / (USD b) 79.2/1.3 52-Week Range (INR) 1,774/589 1, 6, 12 Rel. Per (%) -18/-7/- Financials & Valuation (INR m) Y/E

More information

Shoppers Stop. CMP: INR339 TP: INR355 Neutral

Shoppers Stop. CMP: INR339 TP: INR355 Neutral BSE SENSEX S&P CNX 20,684 6,145 Bloomberg SHOP IN Equity Shares (m) 83.1 M.Cap. (INR b) / (USD b) 28.1/0.5 52-Week Range (INR) 494/331 1, 6, 12 Rel. Per (%) -7/-16/-28 Financials & Valuation (INR b) Y/E

More information

Amara Raja Batteries. CMP: INR517 TP: INR560 Buy

Amara Raja Batteries. CMP: INR517 TP: INR560 Buy BSE SENSEX S&P CNX 25,665 7,672 Bloomberg AMRJ IN Equity Shares (m) 170.8 M.Cap. (INR b) / (USD b) 88.2/1.4 52-Week Range (INR) 520/208 1, 6, 12 Rel. Per (%) 5/21/97 Financials & Valuation (INR Million)

More information

Hardick Bora 4QFY13 Results Update Sector: Healthcare Dr Reddy's Laboratories CMP: INR2,026 TP: INR2,375 Buy

Hardick Bora 4QFY13 Results Update Sector: Healthcare Dr Reddy's Laboratories CMP: INR2,026 TP: INR2,375 Buy BSE Sensex S&P CNX 19,772 5,995 Bloomberg DRRD IN Equity Shares (m) 169.2 M.Cap. (INR b)/(usd b) 344/6.3 52-Week Range (INR) 2,151/1,528 1,6,12 Rel. Perf. (%) -2/9/0 Financials & Valuation (INR b) Y/E

More information

Godrej Properties. CMP: INR368 TP: INR420 Neutral

Godrej Properties. CMP: INR368 TP: INR420 Neutral BSE SENSEX S&P CNX 21,034 6,252 Bloomberg GPL IN Equity Shares (m) 99.6 M.Cap. (INR b) / (USD b) 36.4/ 0.7 52-Week Range (INR) 641/340 1, 6, 12 Rel. Per (%) -1/-44/-47 Financials & Valuation (INR b) Y/E

More information

Shriram Transport Finance

Shriram Transport Finance Results Update SECTOR: BANKING STOCK INFO. BSE Sensex: 18,113 S&P CNX: 5,442 BLOOMBERG SHTF IN REUTERS CODE SRTR.BO Equity Shares (m) 225.5 52-Week Range 651/291 1,6,12 Rel.Perf.(%) -1/12/71 M.Cap. (Rs

More information

Reliance Communications

Reliance Communications 1QFY11 Results Update SECTOR: TELECOM Reliance Communications STOCK INFO. BSE Sensex: 18,167 S&P CNX: 5,452 BLOOMBERG RCOM IN REUTERS CODE RLCM.BO 13 August 2010 Previous Recommendation: Under Review Buy

More information

Jinesh Gandhi Sandipan Pal

Jinesh Gandhi Sandipan Pal BSE Sensex S&P CNX 19,576 5,944 Bloomberg GRASIM IN Equity Shares (m) 91.7 M.Cap. (INR b)/(usd b) 270.6/5.0 52-Week Range (INR) 3,511/2,216 1,6,12 Rel. Perf. (%) 2/-17/5 Financials & Valuation (INR b)

More information

Previous Recommendation: Neutral

Previous Recommendation: Neutral 2QFY11 Results Update SECTOR: PHARMACEUTICALS STOCK INFO. BSE Sensex: 20,589 S&P CNX: 6,194 BLOOMBERG JOL IN REUTERS CODE JUBO.BO Equity Shares (m) 170.0 52-Week Range 413/255 1,6,12 Rel. Perf. (%) -4/-34/-8

More information

Torrent Pharmaceuticals

Torrent Pharmaceuticals BSE SENSEX S&P CNX 21,338 6,339 Bloomberg TRP IN Equity Shares (m) 169.2 M.Cap. (INR b) / (USD b) 80.4/1.3 52-Week Range (INR) 535/324 1, 6, 12 Rel.Per (%) 4/12/32 Financials & Valuation (INR Million)

More information

Godrej Consumer Products

Godrej Consumer Products 3QFY11 Results Update SECTOR: FMCG BSE SENSEX S&P CNX 19,151 5,743 Rs400 Godrej Consumer Products Neutral Bloomberg GCPL IN Equity Shares (m) 323.6 52-Week Range (Rs) 480/225 1,6,12 Rel. Perf. (%) 7/6/46

More information

Jinesh Gandhi Sandipan Pal

Jinesh Gandhi Sandipan Pal BSE Sensex S&P CNX 19,895 6,035 Bloomberg GRASIM IN Equity Shares (m) 91.7 M.Cap. (INR b)/(usd b) 275.8/5.2 52-Week Range (INR) 3,511/2,216 1,6,12 Rel. Perf. (%) -8/-12/-1 Financials & Valuation (INR b)

More information

Dabur India. Neutral. Rs93

Dabur India. Neutral. Rs93 3QFY11 Results Update SECTOR: FMCG BSE SENSEX S&P CNX 18,022 5,417 Bloomberg DABUR IN Equity Shares (m) 1,738.0 52-Week Range (Rs) 112/79 1,6,12 Rel. Perf. (%) 5/-5/2 M.Cap. (Rs b) 160.8 M.Cap. (US$ b)

More information

Punjab National Bank. CMP: INR760 TP: INR964 Buy Asset quality deteriorates; asset-liability well-matched Highlights of FY12 Annual Report

Punjab National Bank. CMP: INR760 TP: INR964 Buy Asset quality deteriorates; asset-liability well-matched Highlights of FY12 Annual Report BSE SENSEX S&P CNX 16,706 5,064 19 June 2012 Annual Report Update Sector: Financials Punjab National Bank CMP: INR760 TP: INR964 Buy Asset quality deteriorates; asset-liability well-matched Highlights

More information